Janney Montgomery Scott
MED icon

Janney Montgomery Scott’s Medifast MED Stock Holding History

Janney Montgomery Scott’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,729
Closed -$489K – 2787
2024
Q4 		$489K Sell
27,729
-2,947
-10% -$54.7K ﹤0.01% 2014
2024
Q3 		$587K Buy
+30,676
New +$591K ﹤0.01% 1872
2022
Q4 		– Sell
-5,761
Closed -$624K – 2607
2022
Q3 		$624K Buy
5,761
+271
+5% +$38.8K ﹤0.01% 1556
2022
Q2 		$1.03M Buy
5,490
+24
+0.4% +$4.29K ﹤0.01% 1230
2022
Q1 		$933K Sell
5,466
-72
-1% -$13.6K ﹤0.01% 1286
2021
Q4 		$1.16M Buy
5,538
+1,542
+39% +$319K ﹤0.01% 1245
2021
Q3 		$770K Buy
+3,996
New +$982K ﹤0.01% 1415
2019
Q3 		– Sell
-2,568
Closed -$329K – 2105
2019
Q2 		$329K Buy
+2,568
New +$357K ﹤0.01% 1649
2018
Q4 		– Sell
-1,600
Closed -$354K – 2007
2018
Q3 		$354K Buy
+1,600
New +$324K ﹤0.01% 1606

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janney Montgomery Scott's MED Position: Q1 2025 in Review

Janney Montgomery Scott sold out of Medifast (MED) in Q1 2025, closing a stake of 27,729 shares — an estimated $489K sold.

Janney Montgomery Scott first reported a position in MED in Q3 2018 and held it in 9 quarters. The position peaked at $1.16M in Q4 2021. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Janney Montgomery Scott reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 27,729 Medifast shares in Q1 2025, an estimated $489K.
  • Janney Montgomery Scott first reported a position in Medifast in Q3 2018 and held it in 9 quarters.
  • Janney Montgomery Scott's Medifast position peaked at $1.16M in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Janney Montgomery Scott's 13F filing for Q1 2025, filed 17 Apr 2025.